GreenLight Biosciences Holdings, PBC

GreenLight Biosciences Holdings, PBC, trading under the ticker ENVI on Nasdaq, went public through a SPAC transaction with Environmental Impact Acquisition Corp, which completed its IPO in 2021 and was sponsored by ENVI Acquisition Sponsor LLC. The company operates in the biotechnology sector, with a focus on RNA-based solutions spanning both human health therapeutics and agricultural applications. An S-1 registration statement was filed with the SEC on February 7, 2022, under accession number 0001193125-22-029838, in connection with the post-combination entity. At the time of filing, GreenLight represented one of the few RNA-platform biotechs to reach public markets via the SPAC structure. Visit SpacDesk and sign up for full data, filings history, and analytics on ENVI and hundreds of other SPAC transactions.